Modus Therapeutics Holding AB (publ)

DB:99Z Stock Report

Market Cap: €3.4m

Modus Therapeutics Holding Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

John Öhd

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.4yrs
CEO ownership4.8%
Management average tenureno data
Board average tenure3.6yrs

Recent management updates

Recent updates


CEO

John Öhd (53 yo)

4.4yrs

Tenure

Dr. John Öhd, M.D., Ph D., has been Chief Executive Officer at Modus Therapeutics AB since June 2020. He serves as Chief Executive Officer Modus Therapeutics Holding Ab since 2020.He had been Chief Medica...


Board Members

NamePositionTenureCompensationOwnership
Viktor Drvota
Chairman of the Board8.4yrsno datano data
Eddie Weitzberg
Scientific Advisor2.8yrsno datano data
Torsten Goesch
Independent Director10.4yrsno datano data
Mats Wahlgren
Scientific Advisor2.8yrsno datano data
Ellen Donnelly
Independent Director4.4yrsno data0.54%
SEK 18.4k
Lennart Lindbom
Scientific Advisor2.8yrsno datano data

3.6yrs

Average Tenure

62yo

Average Age

Experienced Board: 99Z's board of directors are considered experienced (3.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.